Reducing Risk of Type 2 Diabetes Mellitus with Alendronate - A Promising Possibility for the Indian Population.
作者信息
Balaji Ananya, Boratne Abhijit Vinodrao, Mishra Amrit
机构信息
Department of Community Medicine, Mahatma Gandhi Medical College and Research Institute, Puducherry, India.
出版信息
Indian J Pharmacol. 2022 Jan-Feb;54(1):65-66. doi: 10.4103/ijp.ijp_828_21.
Abstract
摘要
相似文献
1
Reducing Risk of Type 2 Diabetes Mellitus with Alendronate - A Promising Possibility for the Indian Population.
Indian J Pharmacol. 2022 Jan-Feb;54(1):65-66. doi: 10.4103/ijp.ijp_828_21.
2
Risk of newly diagnosed type 2 diabetes is reduced in users of alendronate.
Calcif Tissue Int. 2011 Oct;89(4):265-70. doi: 10.1007/s00223-011-9515-z. Epub 2011 Jun 28.
3
Influence of type 2 diabetes mellitus on bone mineral density response to bisphosphonates in late postmenopausal osteoporosis.
Adv Ther. 2007 Nov-Dec;24(6):1314-20. doi: 10.1007/BF02877778.
4
The use of alendronate is associated with a decreased incidence of type 2 diabetes mellitus--a population-based cohort study in Taiwan.
PLoS One. 2015 Apr 13;10(4):e0123279. doi: 10.1371/journal.pone.0123279. eCollection 2015.
5
General Commentary: Alendronate Use and Risk of Type 2 Diabetes: A Nationwide Nested Case-Control Study.
Front Endocrinol (Lausanne). 2022 Jun 6;13:893735. doi: 10.3389/fendo.2022.893735. eCollection 2022.
6
Clinical significance of alendronate in postmenopausal type 2 diabetes mellitus.
Diabetes Metab. 2004 Sep;30(4):355-8. doi: 10.1016/s1262-3636(07)70128-3.
7
[Alendronate--a new drug for treatment of osteoporosis].
Chir Narzadow Ruchu Ortop Pol. 1997;62(1):73-7.
8
Oral alendronate use and risk of cancer in postmenopausal women with osteoporosis: A nationwide study.
J Bone Miner Res. 2012 Sep;27(9):1951-8. doi: 10.1002/jbmr.1645.
9
The effects of metformin and alendronate in attenuating bone loss and improving glucose metabolism in diabetes mellitus mice.
Aging (Albany NY). 2022 Jan 14;14(1):272-285. doi: 10.18632/aging.203729.
10
Alendronate, a bisphosphonate, increased upper and lower gastrointestinal bleeding: risk factor analysis from a nationwide population-based study.
Osteoporos Int. 2014 May;25(5):1617-23. doi: 10.1007/s00198-014-2647-z. Epub 2014 Feb 25.
本文引用的文献
1
Impact of oral anticholinergic on insulin response to oral glucose load in patients with impaired glucose tolerance.
Indian J Pharmacol. 2021 Jul-Aug;53(4):294-297. doi: 10.4103/ijp.IJP_792_19.
2
Prevalence and trends of the diabetes epidemic in urban and rural India: A pooled systematic review and meta-analysis of 1.7 million adults.
Ann Epidemiol. 2021 Jun;58:128-148. doi: 10.1016/j.annepidem.2021.02.016. Epub 2021 Mar 13.
3
Alendronate improves fasting plasma glucose and insulin sensitivity, and decreases insulin resistance in prediabetic osteopenic postmenopausal women: A randomized triple-blind clinical trial.
J Diabetes Investig. 2019 May;10(3):731-737. doi: 10.1111/jdi.12944. Epub 2018 Oct 23.
4
The use of alendronate is associated with a decreased incidence of type 2 diabetes mellitus--a population-based cohort study in Taiwan.
PLoS One. 2015 Apr 13;10(4):e0123279. doi: 10.1371/journal.pone.0123279. eCollection 2015.
5
Bisphosphonates: mechanism of action and role in clinical practice.
Mayo Clin Proc. 2008 Sep;83(9):1032-45. doi: 10.4065/83.9.1032.
Zotero 插件